Global Intrauterine Contraceptive Devices Market Gaining Strong Growth in Asia Pacific Region

The increasing prevalence of unplanned pregnancy is a prime factor influencing the growth of the intrauterine contraceptive devices market.

Additionally, less-side effects associated with these devices are other major factors augmenting the growth of the market. Also, with the use of such devices, there is no need for other contraception every day like contraceptive pills. Moreover, increasing focus on women’s health and guidelines by regulatory authorities is further driving the market growth. For instance, in August 2019, the World Health Organisation (WHO) revised its guidelines on contraceptive use in accordance with new evidence regarding the high risk of HIV in women. The new guidelines state that women should have access to a range of options for contraception, HIV prevention, and treatment, such as progestogen-only injectables, implants, and intrauterine devices (IUDs).

On the other hand, side effects such as heavy menstrual bleeding, which resulting in painful cramps are expected to restrict the growth of the intrauterine contraceptive devices market.

The intrauterine contraceptive devices market is poised to grow by USD 799.85 million during 2021-2025, progressing at a CAGR of over 4% during the forecast period.

LIMITED TIME OFFER – Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount for Buyers USD 2000 OFF On Any Research Report

Buy Now and Get Instant Discount: https://www.coherentmarketinsights.com/promo/buynow/53

The intrauterine contraceptive devices market is segmented as below:
By End-user
• Hospitals
• Gynecology clinics
• Others

By Type
• Hormonal intrauterine device
• Copper intrauterine device

By Geography
• North America
• Europe
• APAC
• ROW

The Asia Pacific is expected to lead the global intrauterine contraceptive devices market owing to growing cases of unplanned pregnancy and rising government initiatives regarding family planning in the region.

In February 2019, Bayer HealthCare AG started the first-ever ad campaign regarding intrauterine devices (IUDs). The goal of the campaign is to explain the purpose of levonorgestrel-releasing IUDs, and also provide basic knowledge about these devices.

Intrauterine devices (IUDs) are among the most effective methods of permanent birth control. Despite their effectiveness, they are also among the most dangerous methods of controlling pregnancy. Many women develop pelvic infections, pelvic inflammatory disease, and other complications after the long use of an IUD. The Intrauterine Device (IUD) has been proven to be an effective form of contraception for women, but its danger should be balanced with good information on how to use it properly.

Intrauterine devices may be inserted into the uterus during pregnancy or within three days of conception; however, long-acting reversible IUDs are not inserted into the uterus. Long-acting reversible IUDs can be inserted by a doctor or purchased over-the-counter and left in the uterus for up to five weeks. These IUDs prevent the release of any eggs by implanting a small, hard shell into the uterus where the egg would normally be released. Some women experience side effects when using an intrauterine contraceptive device including pain, allergic reactions, and pelvic inflammatory disease. Intrauterine devices are one of the most effective forms of contraception but come with the highest risk of complications associated with them.

Read more @ https://www.coherentmarketinsights.com/ongoing-insight/intrauterine-contraceptive-devices-market-53

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle,
WA 98154, U.S.
Phone:
US: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com

About Us:
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. The company’s client base includes players from across various business verticals in over 47 countries globally. It takes pride in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and start-ups looking to establish a foothold in the market.

This release was published on openPR.